share_log

Vivos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Huntsman Ronald Kirk

Vivos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Huntsman Ronald Kirk

Vivos Therapeutics | 4:持股变动声明-高管 Huntsman Ronald Kirk
美股sec公告 ·  06/28 20:57
Moomoo AI 已提取核心信息
Ronald Kirk Huntsman, the Chief Executive Officer of Vivos Therapeutics, Inc. [VVOS], has been reported to hold a total of 73,061 shares in the company following recent transactions. The transactions, which took place on June 20, 2024, involved common stock and resulted in Huntsman holding 3,461 shares directly and 69,600 shares indirectly. The nature of the indirect ownership is detailed in a footnote, which is not disclosed in this summary. The report emphasizes the CEO's continued investment in the company's stock, which could be of interest to current and potential investors.
Ronald Kirk Huntsman, the Chief Executive Officer of Vivos Therapeutics, Inc. [VVOS], has been reported to hold a total of 73,061 shares in the company following recent transactions. The transactions, which took place on June 20, 2024, involved common stock and resulted in Huntsman holding 3,461 shares directly and 69,600 shares indirectly. The nature of the indirect ownership is detailed in a footnote, which is not disclosed in this summary. The report emphasizes the CEO's continued investment in the company's stock, which could be of interest to current and potential investors.
维沃斯治疗公司(Vivos Therapeutics, Inc. [VVOS])首席执行官罗纳德·柯克·亨斯迈(Ronald Kirk Huntsman)在最近的交易中持有总计73,061股公司股票。这些交易发生在2024年6月20日,包括普通股,导致亨斯迈直接持有3,461股,间接持有69,600股。这种间接持有权的性质在脚注中有详细说明,但不在本摘要中披露。报告强调了首席执行官在公司股票中持续投资的情况,这可能对当前和潜在的投资者感兴趣。
维沃斯治疗公司(Vivos Therapeutics, Inc. [VVOS])首席执行官罗纳德·柯克·亨斯迈(Ronald Kirk Huntsman)在最近的交易中持有总计73,061股公司股票。这些交易发生在2024年6月20日,包括普通股,导致亨斯迈直接持有3,461股,间接持有69,600股。这种间接持有权的性质在脚注中有详细说明,但不在本摘要中披露。报告强调了首席执行官在公司股票中持续投资的情况,这可能对当前和潜在的投资者感兴趣。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息